Objective: Review clinical experience with temporal fossa hemangiopericytomas (HPCs).
Study Design: Retrospective case series review.
Setting: Tertiary referral center.
Patients: Intracranial HPCs within the temporal fossa.
Interventions: Craniotomy for either subtotal or gross total tumor excision.
Main Outcome Measures: Determination of clinical outcome (alive with no evidence of disease, alive with disease, and died of disease).
Results: Five cases of HPC involving the temporal fossa were treated at our tertiary referral center for the period from 1995 to 2008. All but 1 patient were men. The age of presentation ranged from 31 to 62 years, and duration of follow-up ranged from 8 to 153 months. Clinical presentation was protean; headache was the most common symptom. Gross total tumor excision was achieved in 2 patients, whereas subtotal tumor excision was achieved in 3 patients. Reasons for subtotal resection included excessive intraoperative blood loss and inextricable tumor. Histologically, all tumors were composed of tightly packed, randomly oriented (jumbled-up) tumor cells with little intervening collagen. CD34 staining mostly highlighted the vascular background. One patient died of disease, 2 patients were alive with disease, and 2 patients had no evidence of disease.
Conclusion: Management of temporal fossa HPC is challenging because clinical presentation is often late, and extent of tumor excision is constrained by vital structures in the cranial base and intracranial contents. A multidisciplinary approach with neurosurgery and neurotology undertaken to achieve the most complete tumor resection possible, whereas minimizing morbidity are likely to confer a longer period of symptom-free survival and improves curability of these difficult lesions.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1097/MAO.0b013e3181b76b58 | DOI Listing |
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!